4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-013846
President, CEO, and Chairman gave up 88,601 shares (to pay taxes)
- President, CEO, and Chairman acquired 99,517 shares (grant or award)
- President, CEO, and Chairman acquired 173,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Option exercise | +173,467 | 290,024 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Grant or award | +99,517 | 389,541 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Shares withheld for taxes | −88,601 | $3.06 | $271,119 | 300,940 | D |
| Derivatives | |||||||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Option exercise · Restricted Stock Units | −173,467 | 173,466 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Grant or award · Restricted Stock Units | +99,518 | 99,518 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2025-01-31 | Grant or award · Stock Option (Right to Buy) | +440,000 | 440,000 | D | ||
Loading xslF345X05/ownership.xml…